A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial

20233 citationsJournal Articlegold Open Access

Authors

NCT04962503, First posted 15/07/2021.

Good health and well-being

Published in: BMC Neurology

Volume 23, Issue 1, pp. 281-281

Field-Weighted Citation Impact: 0.37